Figure 10. The probability of remaining in remission (survival probability) is greater in alefacept-treated patients who have a higher baseline relative frequency of 127-hi cells.

Patients were stratified based on having either lower than the mean (dashed line) or equal to or greater than the mean (solid line) relative frequency of total 127-hi cells (A, n = 11 > mean, n = 20 < mean), 127-hi CM cells (B, n = 13 > mean, n = 18 < mean), 127-hi EM cells (C, n = 16 > mean, n = 15 < mean), and 127-hi naive cells (D, n = 9 > mean, n = 22 < mean) at baseline. Statistical significance was determined using the log-rank (Mantel Cox) test.